Aeromedical Regulation of Aviators Using Selective Serotonin Reuptake Inhibitors for Depressive Disorders

Aviation Space and Environmental Medicine

Volumn 75, Issue 5, 2004, Pages 461-470

  Jones, David R ^a   Ireland, Robert R ^a  

^a Aerospace Medical Association   (United States)

Author keywords

Aviation medicine; Depression; Medical regulation; Pilot certification; Psychiatry; Serotonin specific reuptake inhibitors; Special issuance; SSRIs; Waiver

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BARBITURIC ACID DERIVATIVE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; CYCLOHEXYLAMINE DERIVATIVE; HYPNOTIC AGENT; OPIATE; PHENCYCLIDINE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRANQUILIZER;

AEROSPACE MEDICINE; AIRPLANE CREW; AIRPLANE PILOT; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL PROTOCOL; DEPRESSION; DRUG SAFETY; DRUG UTILIZATION; FLYING; FOLLOW UP; HEALTH CARE POLICY; HUMAN; LAW; LONG TERM CARE; PATIENT CARE; PATIENT MONITORING; PERFORMANCE; PRESCRIPTION; PSYCHOMOTOR RETARDATION; RECURRENT DISEASE; RESTLESSNESS; REVIEW; RISK ASSESSMENT; SEDATION; SIDE EFFECT;

AEROSPACE MEDICINE; DEPRESSIVE DISORDER; HUMANS; SEROTONIN UPTAKE INHIBITORS; SOCIETIES, MEDICAL;

CANNABIS;

EID: 2142660783     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Akin A, Chaturvedi AK. Prevalence of selective serotonin reuptake inhibitors in pilot fatalities of civil aviation accidents, 1990-2001. Oklahoma City, OK: FAA; 2003; DOT/FAA/AAM-03/7.
2. th ed., text revision. Washington, DC: American Psychiatric Association, Inc.; 2000.
3. American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorders. Am J Psychiatry 2000,157: (4 Suppl): 1-45 (325 refs.).
4. Edwards, JG. Depression, antidepressants, and accidents. Br Med J 1995; 311(7010):887-8.
5. Emonson D. Letter to the editor. Aviat Space Environ Med 2002; 73:1241.
6. European Joint Aviation Authorities (JAA). Joint Aviation Requirements. JAR-FCL 3.205 and 3.325, Appendix 10. 2000, amended 2002. Hoofddorp, The Netherlands: The Joint Aviation Authorities; 2002.
7. Federal Aviation Administration. Guide for aviation medical examiners. Washington, DC: U.S. Department of Transportation; 1996.
8. Federal Aviation Agency. Aerospace Medicine Orders and Directives Order 9950.3A, Medical Research Program Guides. Retrieved April 2002 from the World Wide Web: http://www.cami.jccbi.gov/.
9. Grabe HJ, Wolf T, et al. The influence of polypharmacological antidepressive treatment on central nervous information processing of depressed patients: implications for fitness to drive. Neuropsychobiology 1998; 37:200-4.
10. Hindmarch I. A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability. Br J Psychiatry 1988; (3) Suppl:99-104.
11. Hudson DE Jr. SSRI use in professional aircrew. [abstract]. Aviat Space Environ Med 2002; 73:244-5.
12. Hudson DE Jr. SSRI use in professional aircrew. Panel presentation. Aerospace Medical Association annual meeting. 9 May 2002, Montreal, Canada.
13. Ireland RR. Review article: Pharmacologic considerations for serotonin reuptake inhibitor use by aviators. Aviat Space Environ Med 2002; 73:421-9.
14. Ireland RR. Reply to letter by Emonson. Aviat Space Environ Med 2002; 73:1241.
15. nd ed. Baltimore: Williams & Wilkins; 1996: 605.
16. Kerr JS, Fairweather DB, et al. Effects of fluoxetine on psychomotor performance, cognitive function and sleep in depressed patients. Int Clin Psychopharmacol 1993; 8:341-3.
17. Lange M, O'Neill H. Serotonin reuptake inhibitors and the depressed pilot [abstract]. Aviat Space Environ Med 2000; 71:290.
18. Lange M. Maintenance SSRI use in professional pilots: the Canadian experience [abstract]. Aviat Space Environ Med 2002; 73:244.
19. Lange M. Maintenance SSRI use in professional pilots: the Canadian experience. Panel presentation. Aerospace Medical Association annual meeting. 9 May 2002, Montreal, Canada.
20. McKenas DK, Jackson WG. Retrospective cohort analysis of Class A mishaps in aviators evaluated at USAFSAM: 1957-1984. Aviat Space Environ Med 1987; 58:735-41.
21. O'Hanlon JF, Robbe HW, et al. Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens. Journ Clin Psychopharmacol 1998; 18:212-21.
22. Paul M, Gray G, Lange M. The impact of sertraline on psychomotor performance. Aviat Space Environ Med 2002; 73: 964-70.
23. Paul M, et al. The impact of buproprion on psychomotor performance. Aviat Space Environ Med 2002; 73:1084-9.
24. Ramaekers JG, Muntjewerff ND, et al. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 1995; 39:397-404.
25. Ramaekers JG. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 2003; 64(1):20-9.
26. Rayman RB. Aircraft accidents/incidents among aircrewmen flying with a medical waiver. Aerosp Med 1972; 43:1265-9.
27. Robbe HW, O'Hanlon JF. Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol 1995; 5:35-42.
28. Van Syoc D, Chair. SSRI use in professional aircrew. Abstracts. Panel presentation, Aerospace Medical Association annual meeting. 9 May 2002, Montreal, Canada. Aviat Space Environ Med 2002; 73:244-5.
29. Ursano RJ, Jones DR. The individual's versus the organization's doctor: value conflicts in psychiatric aeromedical evaluation. Aviat Space Environ Med 1981; 52:704-6.
30. Voge VM. Role of pre-existing disease in the causation of naval aircraft mishaps. Aviat Space Environ Med 1981; 52:677-82.
31. Weber DK. Aeromedical waiver status in U.S. naval aviators involved in Class A mishaps. Aviat Space Environ Med 2002; 73:791-7.